Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
Shruti Gupta(Harvard University), Sushrut S. Waikar(Metabolism and Renal Physiology), Peter A. McCullough(Parkland Foundation), Anand Srivastava(Northwestern University), Matthew W. Semler(Vanderbilt University Medical Center), Samaya J. Anumudu, Simon Correa(Brigham and Women's Hospital), David E. Leaf(Brigham and Women's Hospital), Adam Green(Morgan Adams Foundation), Jared Radbel(Rutgers, The State University of New Jersey), Andrew J. Admon(University of Michigan), Samuel Short(University of Vermont), Chirag R. Parikh(College of Medicine & JNM Hospital), Amanda K. Leonberg‐Yoo(University of Pennsylvania), Hayley B. Gershengorn(University of Miami), Mary C. Mallappallil(Kings County Hospital Center), Kathleen F. Kopecky, Lili Chan(Icahn School of Medicine at Mount Sinai), Megan L. Krajewski, Carl P. Walther, Samantha K. Brenner(Hackensack University Medical Center), Justin Arunthamakun(Baylor University Medical Center), Michal L. Melamed(NYU Langone Health), Juan Carlos Q. Velez(Ochsner Health System), Jochen Reiser(The University of Texas Medical Branch at Galveston), David J. Douin(University of Colorado Denver), Kapil K. Pokharel(Brigham and Women's Hospital), Anthony J. Faugno(Tufts Medical Center), Thuy-Duyen Nguyen, John P. Donnelly(University of Michigan), Kusum S. Mathews(Mount Sinai Health System), Miguel A. Hernán(Harvard University), Salim S. Hayek(Rush University Medical Center), Gregory P. Milligan, Allon N. Friedman(Yamaha (Japan)), Edward J. Schenck(Cornell University), David M. Charytan(NYU Langone Health), Ambarish M. Athavale(Cook County Health and Hospitals System), Jingjing Zhang(Thomas Jefferson University Hospital), Wei Wang(First Affiliated Hospital of Guangzhou Medical University), Juan D. Valencia, Yan Zhou(National Institute of Metrology), Anip Bansal(University of Colorado Anschutz Medical Campus), Diana G. Finkel(Rutgers, The State University of New Jersey), Shahzad Shaefi(Beth Israel Deaconess Medical Center), Ameeka Pannu, Roberta E. Redfern(ProMedica Toledo Hospital)
Cited by 555
Related Papers
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
|Circulation|2003|3.8k
Clinical Characteristics of Covid-19 in New York City
|New England Journal of Medicine|2020|2.4k
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
|Critical Care|2013|1.4k